Genetic risk factors are responsible for more than half of thromboembolic cases, particularly if the disease occurs before the age of 45 and without any obvious external factors or at untypical localisations. The most important and most frequent genetic risk factors for thrombosis/embolisms are the factor V Leiden and the factor II 20210G>A mutations. Moreover, two polymorphisms in the gene of the methylene tetrahydrofolate reductase (MTHFR) are associated with an increase in homocysteine levels (hyperhomocysteinaemia), which is also considered a risk factor for thrombosis.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
|768||EUROArray||EUROArray FV / FII+ / MTHFR|
|770||EUROArray||EUROArray FV / FII+|
|771||EUROArray||EUROArray FV Leiden|
2023 EUROIMMUN US